392 related articles for article (PubMed ID: 30980732)
1. Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease-associated psychological morbidity.
Bain KA; McDonald E; Moffat F; Tutino M; Castelino M; Barton A; Cavanagh J; Ijaz UZ; Siebert S; McInnes IB; Astrand A; Holmes S; Milling SWF
Br J Dermatol; 2020 Jan; 182(1):130-137. PubMed ID: 30980732
[TBL] [Abstract][Full Text] [Related]
2. The autoimmune basis of alopecia areata: a comprehensive review.
Islam N; Leung PS; Huntley AC; Gershwin ME
Autoimmun Rev; 2015 Feb; 14(2):81-9. PubMed ID: 25315746
[TBL] [Abstract][Full Text] [Related]
3. The profile of cytokines (IL-2, IFN-γ, IL-4, IL-10, IL-17A, and IL-23) in active alopecia areata.
Gautam RK; Singh Y; Gupta A; Arora P; Khurana A; Chitkara A
J Cosmet Dermatol; 2020 Jan; 19(1):234-240. PubMed ID: 31087753
[TBL] [Abstract][Full Text] [Related]
4. The Role of Serum Th1, Th2, and Th17 Cytokines in Patients with Alopecia Areata: Clinical Implications.
Waśkiel-Burnat A; Osińska M; Salińska A; Blicharz L; Goldust M; Olszewska M; Rudnicka L
Cells; 2021 Dec; 10(12):. PubMed ID: 34943905
[TBL] [Abstract][Full Text] [Related]
5. Childhood Alopecia Areata: An Overview of Treatment and Recent Patents.
Hon KL; Luk DCK; Leung AKC; Ng C; Loo SKF
Recent Pat Inflamm Allergy Drug Discov; 2020; 14(2):117-132. PubMed ID: 32723274
[TBL] [Abstract][Full Text] [Related]
6. Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies.
Gilhar A; Schrum AG; Etzioni A; Waldmann H; Paus R
Autoimmun Rev; 2016 Jul; 15(7):726-35. PubMed ID: 26971464
[TBL] [Abstract][Full Text] [Related]
7. Lesional infiltration of mast cells, Langerhans cells, T cells and local cytokine profiles in alopecia areata.
Zhang X; Zhao Y; Ye Y; Li S; Qi S; Yang Y; Cao H; Yang J; Zhang X
Arch Dermatol Res; 2015 May; 307(4):319-31. PubMed ID: 25638328
[TBL] [Abstract][Full Text] [Related]
8. Elucidating the role of T-Reg related cytokines: serum transforming growth factor beta and interleukin-35 in alopecia areata.
Yuksek T; Gonul M; Kartal SP; Gungor EB; Hatil SI
Arch Dermatol Res; 2024 May; 316(6):205. PubMed ID: 38787409
[TBL] [Abstract][Full Text] [Related]
9. Serum cytokine levels and anxiety and depression rates in patients with alopecia areata.
Ataseven A; Saral Y; Godekmerdan A
Eurasian J Med; 2011 Aug; 43(2):99-102. PubMed ID: 25610172
[TBL] [Abstract][Full Text] [Related]
10. Serum T helper 1 cytokine levels are greater in patients with alopecia areata regardless of severity or atopy.
Barahmani N; Lopez A; Babu D; Hernandez M; Donley SE; Duvic M
Clin Exp Dermatol; 2010 Jun; 35(4):409-16. PubMed ID: 19874320
[TBL] [Abstract][Full Text] [Related]
11. Alopecia areata: What's new in the epidemiology, comorbidities, and pathogenesis?
Dainichi T; Iwata M; Kaku Y
J Dermatol Sci; 2023 Dec; 112(3):120-127. PubMed ID: 37833164
[TBL] [Abstract][Full Text] [Related]
12. Increased serum levels of interleukin-17 in patients with alopecia areata and non-segmental vitiligo.
Tomaszewska KA; Kozłowska M; Kaszuba A; Lesiak A; Narbutt J; Zalewska-Janowska AM
Postepy Dermatol Alergol; 2022 Feb; 39(1):195-199. PubMed ID: 35369638
[TBL] [Abstract][Full Text] [Related]
13. T-helper 17 cytokines (interleukins 17, 21, 22, and 6, and tumor necrosis factor-α) in patients with alopecia areata: association with clinical type and severity.
Atwa MA; Youssef N; Bayoumy NM
Int J Dermatol; 2016 Jun; 55(6):666-72. PubMed ID: 26235375
[TBL] [Abstract][Full Text] [Related]
14. The potential role of cytokines and T cells in alopecia areata.
Hoffmann R
J Investig Dermatol Symp Proc; 1999 Dec; 4(3):235-8. PubMed ID: 10674373
[TBL] [Abstract][Full Text] [Related]
15. Immunological Properties of Atopic Dermatitis-Associated Alopecia Areata.
Kageyama R; Ito T; Hanai S; Morishita N; Nakazawa S; Fujiyama T; Honda T; Tokura Y
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807704
[TBL] [Abstract][Full Text] [Related]
16. The association between Interleukin (IL)-4 gene intron 3 VNTR polymorphism and alopecia areata (AA) in Turkish population.
Kalkan G; Karakus N; Baş Y; Takçı Z; Ozuğuz P; Ateş O; Yigit S
Gene; 2013 Sep; 527(2):565-9. PubMed ID: 23831512
[TBL] [Abstract][Full Text] [Related]
17. T-helper and regulatory T-cell cytokines in the peripheral blood of patients with active alopecia areata.
Tembhre MK; Sharma VK
Br J Dermatol; 2013 Sep; 169(3):543-8. PubMed ID: 23607748
[TBL] [Abstract][Full Text] [Related]
18. Alopecia areata: autoimmune basis of hair loss.
Alexis AF; Dudda-Subramanya R; Sinha AA
Eur J Dermatol; 2004; 14(6):364-70. PubMed ID: 15564197
[TBL] [Abstract][Full Text] [Related]
19. Alopecia areata is characterized by expansion of circulating Th2/Tc2/Th22, within the skin-homing and systemic T-cell populations.
Czarnowicki T; He HY; Wen HC; Hashim PW; Nia JK; Malik K; Estrada Y; Kimmel GW; Taliercio M; Krueger JG; Guttman-Yassky E
Allergy; 2018 Mar; 73(3):713-723. PubMed ID: 29083474
[TBL] [Abstract][Full Text] [Related]
20. The role of cytokines and chemokines in the T-cell-mediated autoimmune process in alopecia areata.
Ito T; Tokura Y
Exp Dermatol; 2014 Nov; 23(11):787-91. PubMed ID: 25040075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
